<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Suggested doses for antibiotics recommended in the treatment of suspected staphylococcal or streptococcal skin and soft tissue infections in neonates</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Suggested doses for antibiotics recommended in the treatment of suspected staphylococcal or streptococcal skin and soft tissue infections in neonates</h1>
<div class="graphic"><div class="figure"><div class="ttl">Suggested doses for antibiotics recommended in the treatment of suspected staphylococcal or streptococcal skin and soft tissue infections in neonates</div><div class="cntnt"><table cellspacing="0"><colgroup span="5" width="20%"></colgroup> <tbody> <tr class="divider_bottom"> <td class="subtitle1_left" colspan="5">Parenteral antibiotics for initiation of therapy</td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align" colspan="2"><strong>GA &lt;32 weeks</strong></td> <td class="subtitle3_left_align" colspan="2"><strong>GA ≥32 weeks</strong></td> </tr> <tr> <td class="indent1">Cefazolin</td> <td class="indent1" colspan="2"> <ul> <li>Age &lt;7 days: 25 mg/kg IV every 12 hours</li> <li>Age ≥7 days: 25 mg/kg IV every 8 hours</li> </ul> </td> <td class="indent1" colspan="2" rowspan="3"> <ul> <li>Age ≤7 days: 50 mg/kg IV every 12 hours</li> <li>Age &gt;7 days: 50 mg/kg IV every 8 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Cefotaxime</td> <td class="indent1" colspan="2" rowspan="2"> <ul> <li>Age &lt;7 days: 50 mg/kg IV every 12 hours<br/> Age ≥7 days: 50 mg/kg IV every 8 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Ceftazidime</td> </tr> <tr> <td class="indent1">Ceftriaxone*</td> <td class="indent1" colspan="4"> <ul> <li>50 mg/kg IV every 24 hours</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Clindamycin<sup>¶</sup></td> <td class="indent1" colspan="4"> <ul> <li>PMA ≤32 weeks: 5 mg/kg IV every 8 hours</li> <li>PMA 33 to 40 weeks: 7 mg/kg IV every 8 hours</li> <li>PMA &gt;40 weeks: 9 mg/kg IV every 8 hours</li> </ul> </td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align" colspan="2"><strong>GA &lt;36 weeks</strong></td> <td class="subtitle3_left_align" colspan="2"><strong>GA ≥36 weeks</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">Cefepime</td> <td class="indent1" colspan="2"> <ul> <li>30 mg/kg IV every 12 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>50 mg/kg IV every 12 hours</li> </ul> </td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align" colspan="4"><strong>GA ≥34 weeks and age ≥12 days</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">Ceftaroline</td> <td class="indent1" colspan="4"> <ul> <li>6 mg/kg IV every 8 hours</li> </ul> </td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align"><strong>GA &lt;30 weeks</strong></td> <td class="subtitle3_left_align" colspan="2"><strong>GA 30 to 34 weeks</strong></td> <td class="subtitle3_left_align"><strong>GA ≥35 weeks</strong></td> </tr> <tr class="divider_bottom"> <td class="indent1">Gentamicin<sup>Δ</sup></td> <td class="indent1"> <ul> <li>Age ≤14 days: 5 mg/kg IV every 48 hours</li> <li>Age &gt;14 days: 5 mg/kg IV every 36 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>Age ≤10 days: 5 mg/kg IV every 36 hours</li> <li>Age &gt;10 days: 5 mg/kg IV every 24 hours</li> </ul> </td> <td class="indent1"> <ul> <li>Age ≤7 days: 4 mg/kg IV every 24 hours</li> <li>Age &gt;7 days: 5 mg/kg IV every 24 hours</li> </ul> </td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align" colspan="2"><strong>Age ≤7 days</strong></td> <td class="subtitle3_left_align" colspan="2"><strong>Age 8 to 28 days</strong></td> </tr> <tr> <td class="indent1">Linezolid</td> <td class="indent1" colspan="2"> <ul> <li>GA &lt;34 weeks: 10 mg/kg IV every 12 hours</li> <li>GA ≥34 weeks: 10 mg/kg IV every 8 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>10 mg/kg IV every 8 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Nafcillin</td> <td class="indent1" colspan="2"> <ul> <li>GA ≤34 weeks: 25 mg/kg IV every 12 hours</li> <li>GA &gt;34 weeks: 25 mg/kg IV every 8 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>GA ≤34 weeks: 25 mg/kg IV every 8 hours</li> <li>GA &gt;34 weeks: 25 mg/kg IV every 6 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Oxacillin</td> <td class="indent1" colspan="2"> <ul> <li>GA ≤34 weeks: 25 mg/kg IV every 12 hours</li> <li>GA &gt;34 weeks: 25 mg/kg IV every 8 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>GA ≤34 weeks: 25 mg/kg IV every 8 hours</li> <li>GA &gt;34 weeks: 25 mg/kg IV every 6 hours</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1">Piperacillin-tazobactam<sup>◊</sup></td> <td class="indent1" colspan="4"> <ul> <li>PMA ≤30 weeks: 100 mg/kg IV every 8 hours</li> <li>PMA &gt;30 weeks: 80 mg/kg IV every 6 hours</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1" rowspan="8">Vancomycin<sup>§</sup></td> <td class="highlight_gray_text" colspan="4">Begin with a loading dose of 20 mg/kg followed by maintenance dosing according to GA and serum creatinine as indicated below. The interval between the loading dose and the first maintenance dose should be the same as the dosing interval for the maintenance regimen. This dosing regimen was designed with a target trough concentration of 5 to 10 mg/L<sup>[1]</sup>.</td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" colspan="2">GA ≤28 weeks</td> <td class="subtitle2_left" colspan="2">GA &gt;28 weeks</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align"><strong>Serum creatinine</strong></td> <td class="subtitle3_left_align"><strong>Dose and frequency</strong></td> <td class="subtitle3_left_align"><strong>Serum creatinine</strong></td> <td class="subtitle3_left_align"><strong>Dose and frequency</strong></td> </tr> <tr> <td class="indent1"> <ul> <li>&lt;0.5</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 12 hours</li> </ul> </td> <td class="indent1"> <ul> <li>&lt;0.7</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 12 hours</li> </ul> </td> </tr> <tr> <td class="indent1"> <ul> <li>0.5 to 0.7</li> </ul> </td> <td class="indent1"> <ul> <li>20 mg/kg IV every 24 hours</li> </ul> </td> <td class="indent1"> <ul> <li>0.7 to 0.9</li> </ul> </td> <td class="indent1"> <ul> <li>20 mg/kg IV every 24 hours</li> </ul> </td> </tr> <tr> <td class="indent1"> <ul> <li>0.8 to 1</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 24 hours</li> </ul> </td> <td class="indent1"> <ul> <li>1 to 1.2</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 24 hours</li> </ul> </td> </tr> <tr> <td class="indent1"> <ul> <li>1.1 to 1.4</li> </ul> </td> <td class="indent1"> <ul> <li>10 mg/kg IV every 24 hours</li> </ul> </td> <td class="indent1"> <ul> <li>1.3 to 1.6</li> </ul> </td> <td class="indent1"> <ul> <li>10 mg/kg IV every 24 hours</li> </ul> </td> </tr> <tr class="divider_bottom"> <td class="indent1"> <ul> <li>&gt;1.4</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 48 hours</li> </ul> </td> <td class="indent1"> <ul> <li>&gt;1.6</li> </ul> </td> <td class="indent1"> <ul> <li>15 mg/kg IV every 48 hours</li> </ul> </td> </tr> <tr class="divider_top divider_bottom"> <td class="subtitle1_left" colspan="5">Oral antibiotics for completion of therapy<sup>¥</sup></td> </tr> <tr class="divider_top divider_bottom highlight_green_text"> <td class="subtitle2_left" rowspan="2">Antibiotic agent</td> <td class="subtitle2_left" colspan="4">Dosing</td> </tr> <tr class="divider_bottom"> <td class="subtitle3_left_align" colspan="2"><strong>Age ≤7 days</strong></td> <td class="subtitle3_left_align" colspan="2"><strong>Age 8 to 28 days</strong></td> </tr> <tr> <td class="indent1">Cephalexin</td> <td class="indent1" colspan="2"> <ul> <li>Oral therapy not appropriate</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>6.25 to 12.5 mg/kg orally every 6 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Clindamycin<sup>¶</sup></td> <td class="indent1" colspan="4"> <ul> <li>PMA ≤32 weeks: 5 mg/kg orally every 8 hours</li> <li>PMA 33 to 40 weeks: 7 mg/kg orally every 8 hours</li> <li>PMA &gt;40 weeks: 9 mg/kg orally every 8 hours</li> </ul> </td> </tr> <tr> <td class="indent1">Linezolid<sup>‡</sup></td> <td class="indent1" colspan="2"> <ul> <li>GA &lt;34 weeks: 10 mg/kg orally every 12 hours</li> <li>GA ≥34 weeks: 10 mg/kg orally every 8 hours</li> </ul> </td> <td class="indent1" colspan="2"> <ul> <li>10 mg/kg orally every 8 hours</li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd">This table provides the doses of antibiotics that may be used in the treatment of staphylococcal or streptococcal SSTIs in neonates. Refer to UpToDate content on SSTIs in neonates for details regarding the choice of antimicrobial therapy. Unless otherwise specified, "age" refers to postnatal age.</div><div class="graphic_footnotes">GA: gestational age; IV: intravenously; PMA: postmenstrual age; SSTI: skin and soft tissue infection; MRSA: methicillin-resistant <em>Staphylococcus aureus</em>; MSSA: methicillin-susceptible <em>S. aureus</em>; AUC: area under the curve; PNA: postnatal age.<br/>
* Ceftriaxone should not be administered to neonates if they are also receiving intravenous calcium in any form.<br/>
¶ Monitor carefully when used if more than 15% of local community-associated <em>S. aureus</em> isolates are resistant to clindamycin.<br/>
Δ Gentamicin is necessary to provide coverage for possible gram-negative pathogens. The optimal, individualized dose should be based on determination of serum concentrations. Doses may differ from those recommended by the package insert.<br/>
<span class="lozenge">◊</span> If there is another indication for piperacillin-tazobactam (eg, <em>Pseudomonas</em> infection).<br/>
§ Serum creatinine concentration will take approximately 5 to 7 days after birth to reasonably reflect neonatal renal function. Cautious use of creatinine-based dosing strategy with frequent assessment of renal function and vancomycin serum concentrations are recommended in neonates ≤7 days old<sup>[2]</sup>. A vancomycin dosing method based upon PMA and PNA is provided as an alternative to the serum creatinine-based method listed above and may be useful in some clinical situations<sup>[3]</sup>. The regimen was designed with a target trough concentration of 10 to 20 mg/L.
<ul class="decimal_heading">
<li>PMA ≤29 weeks
    <ul>
<li>PNA ≤21 days: 15 mg/kg IV every 18 hours</li>
<li>PNA &gt;21 days: 15 mg/kg IV every 12 hours</li>
</ul>
</li>
<li>PMA 30 to &lt;37 weeks
    <ul>
<li>PNA ≤14 days: 15 mg/kg IV every 12 hours</li>
<li>PNA &gt;14 days: 15 mg/kg IV every 8 hours</li>
</ul>
</li>
<li>PMA 37 to &lt;45 weeks
    <ul>
<li>PNA ≤7 days: 15 mg/kg IV every 12 hours</li>
<li>PNA &gt;7 days: 15 mg/kg IV every 8 hours</li>
</ul>
</li>
</ul>
The approach to vancomycin dosing (trough-guided or AUC-guided) is generally determined at the institutional level. Refer to UpToDate content on invasive staphylococcal infections in children for details of trough-guided or AUC-guided vancomycin dosing.<br/>
¥ Oral therapy should be directed by results of antibiotic susceptibility testing. If no pathogen is identified, we provide coverage for both MRSA and MSSA (eg, clindamycin).<br/>
‡ Oral linezolid is reserved for isolates resistant to other agents; consultation with an expert in infectious diseases is suggested to ensure that it is the only oral option.</div><div class="graphic_reference">References:
<ol>
<li>Capparelli EV, Lane JR, Romanowski GL, et al. The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol, 2001; 41:927.</li>
<li>Nelson's Pediatric Antimicrobial Therapy, 27<sup>th</sup> ed, Bradley JS, Nelson JD, Barnett ED, et al (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.100.</li>
<li>Radu L, Bengry T, Akierman A, et al. Evolution of empiric vancomycin dosing in a neonatal population. J Perinatol. 2018; 38:1702.</li>
</ol>
Data adapted from: American Academy of Pediatrics. Tables of antibacterial drug dosages. In: Red Book: 2021-2024 Report of the Committee on Infectious Diseases, 32<sup>nd</sup> ed, Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH (Eds), American Academy of Pediatrics, Itasca, IL 2021. p.876.<br/>
Additional data from: Teflaro (ceftaroline fosamil) for injection. United States Prescribing Information. Revised September 2019. US Food &amp; Drug Administration. Available at: <a href="https://www.accessdata.fda.gov/scripts/cder/daf/" target="_blank">https://www.accessdata.fda.gov/scripts/cder/daf/</a> (Accessed on October 22, 2019).</div><div id="graphicVersion">Graphic 107674 Version 13.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
